Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZZ) Equity Ratio (2020 - 2025)

Historic Equity Ratio for Core Scientific (CORZZ) over the last 6 years, with Q3 2025 value amounting to 0.49.

  • Core Scientific's Equity Ratio rose 3791.02% to 0.49 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.49, marking a year-over-year increase of 3791.02%. This contributed to the annual value of 0.51 for FY2024, which is 3879.95% up from last year.
  • Per Core Scientific's latest filing, its Equity Ratio stood at 0.49 for Q3 2025, which was up 3791.02% from 0.54 recorded in Q2 2025.
  • In the past 5 years, Core Scientific's Equity Ratio registered a high of 0.55 during Q4 2021, and its lowest value of 1.44 during Q2 2024.
  • For the 5-year period, Core Scientific's Equity Ratio averaged around 0.31, with its median value being 0.49 (2025).
  • In the last 5 years, Core Scientific's Equity Ratio surged by 64169.62% in 2022 and then plummeted by 124114.35% in 2023.
  • Over the past 5 years, Core Scientific's Equity Ratio (Quarter) stood at 0.55 in 2021, then plummeted by 192.16% to 0.51 in 2022, then tumbled by 65.39% to 0.84 in 2023, then skyrocketed by 38.8% to 0.51 in 2024, then increased by 4.23% to 0.49 in 2025.
  • Its Equity Ratio stands at 0.49 for Q3 2025, versus 0.54 for Q2 2025 and 0.11 for Q1 2025.